 | • レポートコード：GIR-23F0682 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、78ページ • 納品方法：Eメール（2~3営業日） • 産業分類：化学＆材料 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Intramuscular Immune Globulin Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の筋注用免疫グロブリン製剤の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 筋注用免疫グロブリン製剤市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・10mLバイアル、2.0mLバイアル アプリケーション別セグメントは次のように区分されます。 ・A型肝炎、はしか、その他 世界の筋注用免疫グロブリン製剤市場の主要なマーケットプレーヤーは以下のとおりです。 ・Grifols Therapeutics 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 筋注用免疫グロブリン製剤の概要 - タイプ別分析（2017年vs2021年vs2028年）：10mLバイアル、2.0mLバイアル - アプリケーション別分析（2017年vs2021年vs2028年）：A型肝炎、はしか、その他 - 世界の筋注用免疫グロブリン製剤市場規模・予測 - 世界の筋注用免疫グロブリン製剤生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Grifols Therapeutics ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：10mLバイアル、2.0mLバイアル ・アプリケーション別分析2017年-2028年：A型肝炎、はしか、その他 ・筋注用免疫グロブリン製剤の北米市場分析 - 筋注用免疫グロブリン製剤の北米市場：タイプ別市場規模2017年-2028年 - 筋注用免疫グロブリン製剤の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・筋注用免疫グロブリン製剤のヨーロッパ市場分析 - ：筋注用免疫グロブリン製剤のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：筋注用免疫グロブリン製剤のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・筋注用免疫グロブリン製剤のアジア太平洋市場分析 - 筋注用免疫グロブリン製剤のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 筋注用免疫グロブリン製剤のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・筋注用免疫グロブリン製剤の南米市場分析 - 筋注用免疫グロブリン製剤の南米市場：タイプ別市場規模2017年-2028年 - 筋注用免疫グロブリン製剤の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・筋注用免疫グロブリン製剤の中東・アフリカ市場分析 - 筋注用免疫グロブリン製剤の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 筋注用免疫グロブリン製剤の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Intramuscular Immune Globulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Intramuscular Immune Globulin market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hepatitis A accounting for % of the Intramuscular Immune Globulin global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 10mL Vial segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Intramuscular Immune Globulin include Grifols Therapeutics, , , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Intramuscular Immune Globulin market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
10mL Vial
2.0mL Vial
Market segment by Application can be divided into
Hepatitis A
Measles
Others
The key market players for global Intramuscular Immune Globulin market are listed below:
Grifols Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intramuscular Immune Globulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Intramuscular Immune Globulin, with price, sales, revenue and global market share of Intramuscular Immune Globulin from 2019 to 2022.
Chapter 3, the Intramuscular Immune Globulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intramuscular Immune Globulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Intramuscular Immune Globulin market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Intramuscular Immune Globulin.
Chapter 13, 14, and 15, to describe Intramuscular Immune Globulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Intramuscular Immune Globulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Intramuscular Immune Globulin Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 10mL Vial
1.2.3 2.0mL Vial
1.3 Market Analysis by Application
1.3.1 Overview: Global Intramuscular Immune Globulin Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hepatitis A
1.3.3 Measles
1.3.4 Others
1.4 Global Intramuscular Immune Globulin Market Size & Forecast
1.4.1 Global Intramuscular Immune Globulin Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Intramuscular Immune Globulin Sales in Volume (2017-2028)
1.4.3 Global Intramuscular Immune Globulin Price (2017-2028)
1.5 Global Intramuscular Immune Globulin Production Capacity Analysis
1.5.1 Global Intramuscular Immune Globulin Total Production Capacity (2017-2028)
1.5.2 Global Intramuscular Immune Globulin Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Intramuscular Immune Globulin Market Drivers
1.6.2 Intramuscular Immune Globulin Market Restraints
1.6.3 Intramuscular Immune Globulin Trends Analysis
2 Manufacturers Profiles
2.1 Grifols Therapeutics
2.1.1 Grifols Therapeutics Details
2.1.2 Grifols Therapeutics Major Business
2.1.3 Grifols Therapeutics Intramuscular Immune Globulin Product and Services
2.1.4 Grifols Therapeutics Intramuscular Immune Globulin Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Intramuscular Immune Globulin Breakdown Data by Manufacturer
3.1 Global Intramuscular Immune Globulin Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Intramuscular Immune Globulin Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Intramuscular Immune Globulin
3.4 Market Concentration Rate
3.4.1 Top 3 Intramuscular Immune Globulin Manufacturer Market Share in 2021
3.4.2 Top 6 Intramuscular Immune Globulin Manufacturer Market Share in 2021
3.5 Global Intramuscular Immune Globulin Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Intramuscular Immune Globulin Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Intramuscular Immune Globulin Market Size by Region
4.1.1 Global Intramuscular Immune Globulin Sales in Volume by Region (2017-2028)
4.1.2 Global Intramuscular Immune Globulin Revenue by Region (2017-2028)
4.2 North America Intramuscular Immune Globulin Revenue (2017-2028)
4.3 Europe Intramuscular Immune Globulin Revenue (2017-2028)
4.4 Asia-Pacific Intramuscular Immune Globulin Revenue (2017-2028)
4.5 South America Intramuscular Immune Globulin Revenue (2017-2028)
4.6 Middle East and Africa Intramuscular Immune Globulin Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Intramuscular Immune Globulin Sales in Volume by Type (2017-2028)
5.2 Global Intramuscular Immune Globulin Revenue by Type (2017-2028)
5.3 Global Intramuscular Immune Globulin Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Intramuscular Immune Globulin Sales in Volume by Application (2017-2028)
6.2 Global Intramuscular Immune Globulin Revenue by Application (2017-2028)
6.3 Global Intramuscular Immune Globulin Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Intramuscular Immune Globulin Sales by Type (2017-2028)
7.2 North America Intramuscular Immune Globulin Sales by Application (2017-2028)
7.3 North America Intramuscular Immune Globulin Market Size by Country
7.3.1 North America Intramuscular Immune Globulin Sales in Volume by Country (2017-2028)
7.3.2 North America Intramuscular Immune Globulin Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Intramuscular Immune Globulin Sales by Type (2017-2028)
8.2 Europe Intramuscular Immune Globulin Sales by Application (2017-2028)
8.3 Europe Intramuscular Immune Globulin Market Size by Country
8.3.1 Europe Intramuscular Immune Globulin Sales in Volume by Country (2017-2028)
8.3.2 Europe Intramuscular Immune Globulin Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Intramuscular Immune Globulin Sales by Type (2017-2028)
9.2 Asia-Pacific Intramuscular Immune Globulin Sales by Application (2017-2028)
9.3 Asia-Pacific Intramuscular Immune Globulin Market Size by Region
9.3.1 Asia-Pacific Intramuscular Immune Globulin Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Intramuscular Immune Globulin Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Intramuscular Immune Globulin Sales by Type (2017-2028)
10.2 South America Intramuscular Immune Globulin Sales by Application (2017-2028)
10.3 South America Intramuscular Immune Globulin Market Size by Country
10.3.1 South America Intramuscular Immune Globulin Sales in Volume by Country (2017-2028)
10.3.2 South America Intramuscular Immune Globulin Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Intramuscular Immune Globulin Sales by Type (2017-2028)
11.2 Middle East & Africa Intramuscular Immune Globulin Sales by Application (2017-2028)
11.3 Middle East & Africa Intramuscular Immune Globulin Market Size by Country
11.3.1 Middle East & Africa Intramuscular Immune Globulin Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Intramuscular Immune Globulin Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Intramuscular Immune Globulin and Key Manufacturers
12.2 Manufacturing Costs Percentage of Intramuscular Immune Globulin
12.3 Intramuscular Immune Globulin Production Process
12.4 Intramuscular Immune Globulin Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Intramuscular Immune Globulin Typical Distributors
13.3 Intramuscular Immune Globulin Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Intramuscular Immune Globulin Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Intramuscular Immune Globulin Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Grifols Therapeutics Basic Information, Manufacturing Base and Competitors
Table 4. Grifols Therapeutics Major Business
Table 5. Grifols Therapeutics Intramuscular Immune Globulin Product and Services
Table 6. Grifols Therapeutics Intramuscular Immune Globulin Sales (Kiloton), Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Global Intramuscular Immune Globulin Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Kiloton)
Table 8. Global Intramuscular Immune Globulin Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 9. Market Position of Manufacturers in Intramuscular Immune Globulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 10. Global Intramuscular Immune Globulin Production Capacity by Company, (Kiloton): 2020 VS 2021
Table 11. Head Office and Intramuscular Immune Globulin Production Site of Key Manufacturer
Table 12. Intramuscular Immune Globulin New Entrant and Capacity Expansion Plans
Table 13. Intramuscular Immune Globulin Mergers & Acquisitions in the Past Five Years
Table 14. Global Intramuscular Immune Globulin Sales by Region (2017-2022) & (Kiloton)
Table 15. Global Intramuscular Immune Globulin Sales by Region (2023-2028) & (Kiloton)
Table 16. Global Intramuscular Immune Globulin Revenue by Region (2017-2022) & (USD Million)
Table 17. Global Intramuscular Immune Globulin Revenue by Region (2023-2028) & (USD Million)
Table 18. Global Intramuscular Immune Globulin Sales by Type (2017-2022) & (Kiloton)
Table 19. Global Intramuscular Immune Globulin Sales by Type (2023-2028) & (Kiloton)
Table 20. Global Intramuscular Immune Globulin Revenue by Type (2017-2022) & (USD Million)
Table 21. Global Intramuscular Immune Globulin Revenue by Type (2023-2028) & (USD Million)
Table 22. Global Intramuscular Immune Globulin Price by Type (2017-2022) & (US$/Ton)
Table 23. Global Intramuscular Immune Globulin Price by Type (2023-2028) & (US$/Ton)
Table 24. Global Intramuscular Immune Globulin Sales by Application (2017-2022) & (Kiloton)
Table 25. Global Intramuscular Immune Globulin Sales by Application (2023-2028) & (Kiloton)
Table 26. Global Intramuscular Immune Globulin Revenue by Application (2017-2022) & (USD Million)
Table 27. Global Intramuscular Immune Globulin Revenue by Application (2023-2028) & (USD Million)
Table 28. Global Intramuscular Immune Globulin Price by Application (2017-2022) & (US$/Ton)
Table 29. Global Intramuscular Immune Globulin Price by Application (2023-2028) & (US$/Ton)
Table 30. North America Intramuscular Immune Globulin Sales by Country (2017-2022) & (Kiloton)
Table 31. North America Intramuscular Immune Globulin Sales by Country (2023-2028) & (Kiloton)
Table 32. North America Intramuscular Immune Globulin Revenue by Country (2017-2022) & (USD Million)
Table 33. North America Intramuscular Immune Globulin Revenue by Country (2023-2028) & (USD Million)
Table 34. North America Intramuscular Immune Globulin Sales by Type (2017-2022) & (Kiloton)
Table 35. North America Intramuscular Immune Globulin Sales by Type (2023-2028) & (Kiloton)
Table 36. North America Intramuscular Immune Globulin Sales by Application (2017-2022) & (Kiloton)
Table 37. North America Intramuscular Immune Globulin Sales by Application (2023-2028) & (Kiloton)
Table 38. Europe Intramuscular Immune Globulin Sales by Country (2017-2022) & (Kiloton)
Table 39. Europe Intramuscular Immune Globulin Sales by Country (2023-2028) & (Kiloton)
Table 40. Europe Intramuscular Immune Globulin Revenue by Country (2017-2022) & (USD Million)
Table 41. Europe Intramuscular Immune Globulin Revenue by Country (2023-2028) & (USD Million)
Table 42. Europe Intramuscular Immune Globulin Sales by Type (2017-2022) & (Kiloton)
Table 43. Europe Intramuscular Immune Globulin Sales by Type (2023-2028) & (Kiloton)
Table 44. Europe Intramuscular Immune Globulin Sales by Application (2017-2022) & (Kiloton)
Table 45. Europe Intramuscular Immune Globulin Sales by Application (2023-2028) & (Kiloton)
Table 46. Asia-Pacific Intramuscular Immune Globulin Sales by Region (2017-2022) & (Kiloton)
Table 47. Asia-Pacific Intramuscular Immune Globulin Sales by Region (2023-2028) & (Kiloton)
Table 48. Asia-Pacific Intramuscular Immune Globulin Revenue by Region (2017-2022) & (USD Million)
Table 49. Asia-Pacific Intramuscular Immune Globulin Revenue by Region (2023-2028) & (USD Million)
Table 50. Asia-Pacific Intramuscular Immune Globulin Sales by Type (2017-2022) & (Kiloton)
Table 51. Asia-Pacific Intramuscular Immune Globulin Sales by Type (2023-2028) & (Kiloton)
Table 52. Asia-Pacific Intramuscular Immune Globulin Sales by Application (2017-2022) & (Kiloton)
Table 53. Asia-Pacific Intramuscular Immune Globulin Sales by Application (2023-2028) & (Kiloton)
Table 54. South America Intramuscular Immune Globulin Sales by Country (2017-2022) & (Kiloton)
Table 55. South America Intramuscular Immune Globulin Sales by Country (2023-2028) & (Kiloton)
Table 56. South America Intramuscular Immune Globulin Revenue by Country (2017-2022) & (USD Million)
Table 57. South America Intramuscular Immune Globulin Revenue by Country (2023-2028) & (USD Million)
Table 58. South America Intramuscular Immune Globulin Sales by Type (2017-2022) & (Kiloton)
Table 59. South America Intramuscular Immune Globulin Sales by Type (2023-2028) & (Kiloton)
Table 60. South America Intramuscular Immune Globulin Sales by Application (2017-2022) & (Kiloton)
Table 61. South America Intramuscular Immune Globulin Sales by Application (2023-2028) & (Kiloton)
Table 62. Middle East & Africa Intramuscular Immune Globulin Sales by Region (2017-2022) & (Kiloton)
Table 63. Middle East & Africa Intramuscular Immune Globulin Sales by Region (2023-2028) & (Kiloton)
Table 64. Middle East & Africa Intramuscular Immune Globulin Revenue by Region (2017-2022) & (USD Million)
Table 65. Middle East & Africa Intramuscular Immune Globulin Revenue by Region (2023-2028) & (USD Million)
Table 66. Middle East & Africa Intramuscular Immune Globulin Sales by Type (2017-2022) & (Kiloton)
Table 67. Middle East & Africa Intramuscular Immune Globulin Sales by Type (2023-2028) & (Kiloton)
Table 68. Middle East & Africa Intramuscular Immune Globulin Sales by Application (2017-2022) & (Kiloton)
Table 69. Middle East & Africa Intramuscular Immune Globulin Sales by Application (2023-2028) & (Kiloton)
Table 70. Intramuscular Immune Globulin Raw Material
Table 71. Key Manufacturers of Intramuscular Immune Globulin Raw Materials
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Intramuscular Immune Globulin Typical Distributors
Table 75. Intramuscular Immune Globulin Typical Customers
List of Figures
Figure 1. Intramuscular Immune Globulin Picture
Figure 2. Global Intramuscular Immune Globulin Revenue Market Share by Type in 2021
Figure 3. 10mL Vial
Figure 4. 2.0mL Vial
Figure 5. Global Intramuscular Immune Globulin Revenue Market Share by Application in 2021
Figure 6. Hepatitis A
Figure 7. Measles
Figure 8. Others
Figure 9. Global Intramuscular Immune Globulin Revenue, (USD Million) & (Kiloton): 2017 & 2021 & 2028
Figure 10. Global Intramuscular Immune Globulin Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Intramuscular Immune Globulin Sales (2017-2028) & (Kiloton)
Figure 12. Global Intramuscular Immune Globulin Price (2017-2028) & (US$/Ton)
Figure 13. Global Intramuscular Immune Globulin Production Capacity (2017-2028) & (Kiloton)
Figure 14. Global Intramuscular Immune Globulin Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Intramuscular Immune Globulin Market Drivers
Figure 16. Intramuscular Immune Globulin Market Restraints
Figure 17. Intramuscular Immune Globulin Market Trends
Figure 18. Global Intramuscular Immune Globulin Sales Market Share by Manufacturer in 2021
Figure 19. Global Intramuscular Immune Globulin Revenue Market Share by Manufacturer in 2021
Figure 20. Intramuscular Immune Globulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Intramuscular Immune Globulin Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Intramuscular Immune Globulin Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Intramuscular Immune Globulin Sales Market Share by Region (2017-2028)
Figure 24. Global Intramuscular Immune Globulin Revenue Market Share by Region (2017-2028)
Figure 25. North America Intramuscular Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 26. Europe Intramuscular Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Intramuscular Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 28. South America Intramuscular Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Intramuscular Immune Globulin Revenue (2017-2028) & (USD Million)
Figure 30. Global Intramuscular Immune Globulin Sales Market Share by Type (2017-2028)
Figure 31. Global Intramuscular Immune Globulin Revenue Market Share by Type (2017-2028)
Figure 32. Global Intramuscular Immune Globulin Price by Type (2017-2028) & (US$/Ton)
Figure 33. Global Intramuscular Immune Globulin Sales Market Share by Application (2017-2028)
Figure 34. Global Intramuscular Immune Globulin Revenue Market Share by Application (2017-2028)
Figure 35. Global Intramuscular Immune Globulin Price by Application (2017-2028) & (US$/Ton)
Figure 36. North America Intramuscular Immune Globulin Sales Market Share by Type (2017-2028)
Figure 37. North America Intramuscular Immune Globulin Sales Market Share by Application (2017-2028)
Figure 38. North America Intramuscular Immune Globulin Sales Market Share by Country (2017-2028)
Figure 39. North America Intramuscular Immune Globulin Revenue Market Share by Country (2017-2028)
Figure 40. United States Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Intramuscular Immune Globulin Sales Market Share by Type (2017-2028)
Figure 44. Europe Intramuscular Immune Globulin Sales Market Share by Application (2017-2028)
Figure 45. Europe Intramuscular Immune Globulin Sales Market Share by Country (2017-2028)
Figure 46. Europe Intramuscular Immune Globulin Revenue Market Share by Country (2017-2028)
Figure 47. Germany Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Intramuscular Immune Globulin Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Intramuscular Immune Globulin Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Intramuscular Immune Globulin Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Intramuscular Immune Globulin Revenue Market Share by Region (2017-2028)
Figure 56. China Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Intramuscular Immune Globulin Sales Market Share by Type (2017-2028)
Figure 63. South America Intramuscular Immune Globulin Sales Market Share by Application (2017-2028)
Figure 64. South America Intramuscular Immune Globulin Sales Market Share by Country (2017-2028)
Figure 65. South America Intramuscular Immune Globulin Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Intramuscular Immune Globulin Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Intramuscular Immune Globulin Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Intramuscular Immune Globulin Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Intramuscular Immune Globulin Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Intramuscular Immune Globulin Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Intramuscular Immune Globulin in 2021
Figure 77. Manufacturing Process Analysis of Intramuscular Immune Globulin
Figure 78. Intramuscular Immune Globulin Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source